, Volume 180, Issue 1, pp 141–149 | Cite as

The nature of ecstasy-group related deficits in associative learning

  • Catharine Montgomery
  • John E. FiskEmail author
  • Russell Newcombe
Original Investigation



Research has revealed associative learning deficits among users of ecstasy; the present study explored the component processes underlying these deficits.


Thirty-five ecstasy users and 62 non-ecstasy users completed a computer-based, verbal paired-associates learning task. Participants attempted to learn eight sequentially presented word pairs. After all eight had been presented, the first member of each pair was displayed and participants attempted to recall the second. Eight trials were administered. Correct responses on each trial, forgetting at various levels of learning, perseveration errors and the rate at which the associations were learned (trials to completion) were all recorded.


MANOVA revealed that ecstasy users performed worse overall and subsequent ANOVAs showed that users performed significantly worse on virtually all measures. Regression analysis revealed that over half of the ecstasy-group related variance in trials to completion was attributable to group differences in initial learning and forgetting. In relation to forgetting, it appears that cannabis use may be an important determinant. In relation to rate of learning (trials to completion) and initial learning, both ecstasy and cannabis may be implicated.


There appears to be abundant evidence of associative learning deficits among ecstasy users. However, it appears that a range of illicit drugs including cannabis and ecstasy may contribute to these deficits.


Ecstasy MDMA Learning Paired associate learning Cannabis 


  1. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001) 3,4-Methylenedioxymethamphetamine (ecstasy) induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21(9):3228–3235Google Scholar
  2. Cole J, Bailey M, Sumnall HR, Wagstaff GF, King LA (2002) The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97:1531–1536CrossRefGoogle Scholar
  3. Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379CrossRefGoogle Scholar
  4. Dafters RI, Hoshi R, Talbot AC (2004) Contribution of cannabis and MDMA (“ecstasy”) to cognitive changes in long term polydrug users. Psychopharmacology 173:405–410CrossRefGoogle Scholar
  5. Fisk JE (2003) Age differences in associative learning: the role working memory and executive processes. Proc Br Psychol Soc 11:270Google Scholar
  6. Fisk JE, Montgomery C, Murphy P, Wareing M (2004) Evidence for executive deficits among users of MDMA (Ecstasy). Br J Psychol 95:457–466CrossRefGoogle Scholar
  7. Fox HC, McLean A, Turner JJD, Parrot AC, Rogers R, Sahakian BJ (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology 162:203–214CrossRefPubMedGoogle Scholar
  8. Frederick DL, Paule MG (1997) Effects of MDMA on complex brain functions in laboratory animals. Neurosci Biobehav Rev 21:67–78CrossRefGoogle Scholar
  9. Frederick DL, Ali SF, Slikker W, Gillam MP, Allen RR, Paule MG (1995) Behavioural and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neurotoxicol Teratol 17(5):531–543CrossRefGoogle Scholar
  10. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H (2000) Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users. J Neurol Neurosurg Psychiatry 68:719–725CrossRefPubMedGoogle Scholar
  11. Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuro-psychopharmacol Biol Psychiatry 27:819–827CrossRefGoogle Scholar
  12. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540–545PubMedGoogle Scholar
  13. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173:434–439CrossRefPubMedGoogle Scholar
  14. Montgomery C, Fisk J E, Newcombe R, Wareing M, Murphy P (in press) Syllogistic reasoning performance in MDMA (Ecstasy) users. Exp Clin PsychopharmacolGoogle Scholar
  15. Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264CrossRefPubMedGoogle Scholar
  16. Morgan MJ (1999) Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 141:30–36CrossRefPubMedGoogle Scholar
  17. Morgan MJ, McFie L, Fleetwood LH, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294–303CrossRefGoogle Scholar
  18. Nelson HE (1982) National Adult Reading Test (NART) test manual. NFER-Nelson, Windsor, Berkshire, UKGoogle Scholar
  19. O’Shea E, Grandos R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (‘ecstasy’). Neuropharmacology 37:919–926CrossRefGoogle Scholar
  20. Parrot AC, Lasky J (1998) Ecstasy (MDMA effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268CrossRefGoogle Scholar
  21. Raven J, Raven JC, Court JH (1998) Manual for Raven’s progressive matrices and vocabulary scales. Oxford Psychologists Press, Oxford, UKGoogle Scholar
  22. Reneman L, Booij J, Schmand B, Brink W, Gunning B (2000) Memory disturbances in ecstasy users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148:322–324CrossRefGoogle Scholar
  23. Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS (1993) 3,4-methylenedioxymethamphetamine, serotonin, and memory. J Pharmacol Exp Ther 266(2):1097–1105Google Scholar
  24. Robinson TE, Castaneda E, Whishaw IQ (1993) Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine on behaviour, before and after additional cholinergic blockade. Neuropsychopharmacology 8(1):77–85Google Scholar
  25. Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology 151:19–24CrossRefGoogle Scholar
  26. Romano AG, Harvey JA (1993) MDMA enhances associative and non-associative learning in the rabbit. Pharmacol Biochem Behav 47:289–293CrossRefGoogle Scholar
  27. Rose M, Verleger R, Wascher E (2001) ERP correlates of associative learning. Psychophysiology 38:440–450Google Scholar
  28. Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of ecstasy users and their experiences with the drug. Br J Addict 87:1161–1172Google Scholar
  29. Tanji J, Hoshi E (2001) Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 11:164–170CrossRefGoogle Scholar
  30. Taylor JR, Jentsch JD (2001) Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behaviour in rats: differential effects of cocaine, d-amphetamine, and 3,4-methylenedioxynethamphetamine (“ecstasy”). Biol Psychiatry 50:137–143CrossRefPubMedGoogle Scholar
  31. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy users. Psychopharmacology 167:85–96Google Scholar
  32. Uitenbroek D (2004) Simple interactive statistical analysis. Retrieved on November 18, 2004 from:
  33. Wareing M, Fisk JE, Murphy PN (2000) Working memory deficits in current and previous users of MDMA (“ecstasy”). Br J Psychol 91:181–188CrossRefPubMedGoogle Scholar
  34. Wareing M, Fisk JE, Murphy PN, Montgomery CA (2004) Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol 19:225–234CrossRefGoogle Scholar
  35. Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV (2003) Developmental 3,4-methylenedioxymethamphetamine impairs sequential and spatial, but not cued learning, independent of growth, litter effects or injection stress. Brain Res 968:89–101CrossRefGoogle Scholar
  36. Winsaeur PJ, McCann UD, Yuan J, Delatte MS, Stevenson MV, Ricaurte GA, Moerschbaecher JM (2002) Effects of fenfluramine mCPP and triazolam on repeated acquisition in squirrel monkeys before and after neurotoxic MDMA. Psychopharmacology 159:388–396CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Catharine Montgomery
    • 1
  • John E. Fisk
    • 1
    Email author
  • Russell Newcombe
    • 1
  1. 1.School of PsychologyLiverpool John Moores UniversityLiverpoolUK

Personalised recommendations